MitoQ Mitoquinone supplementation for targeted health support.
Regular CoQ10 doesn't concentrate in mitochondria well. MitoQ has a targeting molecule (triphenylphosphonium) that drives it into mitochondria, achieving much higher local concentrations.
Yes, because MitoQ concentrates 100-1000x in mitochondria. Lower systemic dose, higher mitochondrial dose.
Research suggests it may address aspects of mitochondrial aging. Human longevity studies are limited, but the mechanism is solid for 'aging' at the cellular level.
Click through to the studies bar for the evidence base.
See the dosing guide below.
Compare formats before buying.
Some ingredients build up over weeks. Others act fast.
The compound effect of consistent dosing.
Check the cautions section if you have a pre-existing condition.
Some ingredients you feel. Others just work in the background.
If mitochondrial targeting matters for your goals (energy, exercise, cardiovascular health), yes. For general antioxidant support, regular CoQ10 is cheaper.
MitoQ was developed by researchers at the University of Otago (New Zealand) and Cambridge University. It's a patented, well-researched molecule.
Generally well-tolerated. Some report mild GI effects initially. No major safety concerns in clinical trials.
Most research uses 0.0g daily. Below 0.0g, you're probably wasting money. Above 0.0g, no extra benefit. The curve plateaus. Safe upper limit ~ 0.1g.
MitoQ Mitoquinone has emerging evidence.
Synthetic. Modified CoQ10 with triphenylphosphonium cation for mitochondrial targeting.
MitoQ Mitoquinone interacts with other supplements and meds. The analyzer flags interactions, dose mismatches, and timing collisions across your whole list.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.